NEULANDLAB

Neuland Laboratories Ltd.

18,889.00-11.0 (-0.06%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Neuland Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Neuland Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20182 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
  • Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Closure of Trading Window
  • Newspaper Publication16 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication
  • Analyst / Investor Meet5 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation about Schedule of Analyst / Institutional Investor Meeting on June 11, 2026
  • Analyst / Investor Meet3 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9, 2026
  • Analyst / Investor Meet31 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation about Schedule of Analyst / Institutional Investor Meeting on June 5, 2026
  • Analyst / Investor Meet22 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation about Schedule of Analyst / Institutional Investor Meeting on May 28, 2026
  • Newspaper Publication15 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication
  • Newspaper Publication13 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication
  • Analyst / Investor Meet12 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of the Earnings call conducted on May 12, 2026
  • Press Release / Media Release (Revised)12 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
    Correction in Press Release Header
  • Dividend Updates12 May 2026
    Announcement under Regulation 30 (LODR)-Dividend Updates
    Recommendation of final dividend for the financial year 2025-26
  • AGM12 May 2026
    42Nd Annual General Meeting Of The Shareholders Of The Company Is Scheduled To Be Held On Tuesday, August 4, 2026
    42nd Annual General Meeting of the Shareholders of the Company is scheduled to be held on Tuesday, August 4, 2026
  • Record Date12 May 2026
    The Record Date For The Purpose Of Determining The Shareholder Eligible To Receive The Final Dividend For The Financial Year Ended March 31, 2026, Has Been Fixed As July 24, 2026
    The Record Date for the Purpose of Determining the Shareholder Eligible to receive the final dividend for the financial year ended March 31, 2026, has been fixed as July 24, 2026
  • General12 May 2026
    Disclosure Under Regulation 30 Of SEBI Listing Regulations
    Disclosure under Regulation 30 of SEBI Listing Regulations
  • Change in Directorate12 May 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Appointment of Dr. Mauricio Futran (DIN: 11699767), as an Additional Director of the Company categorized as Non-Executive Non-Independent
  • Press Release / Media Release (Revised)12 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
    Error in the Earnings Call Link
  • Dividend12 May 2026
    Corporate Action-Board approves Dividend
    Recommendation of final dividend for the financial year 2025-26
  • Press Release / Media Release12 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on the Financial Results of the Company for the quarter and year ended March 31, 2026
  • Outcome of Board Meeting12 May 2026
    Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2025-26
    Audited Financial Results and recommendation of final dividend for financial year 2025-26

Frequently Asked Questions

Where can I download the annual report of Neuland Laboratories Ltd.?
Annual reports of Neuland Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Neuland Laboratories Ltd.?
Quarterly earnings results and presentations of Neuland Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Neuland Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Neuland Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Neuland Laboratories Ltd.?
Investor presentations and annual day presentations of Neuland Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Neuland Laboratories Ltd.?
Corporate announcements and regulatory filings of Neuland Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Neuland Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Neuland Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Neuland Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Neuland Laboratories Ltd. is INE794A01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Neuland Laboratories Ltd. listed?
Neuland Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is NEULANDLAB and the BSE code is -.
Where can I find the shareholding pattern of Neuland Laboratories Ltd.?
The quarterly shareholding pattern of Neuland Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Neuland Laboratories Ltd. on Sharpely?
Share price data for Neuland Laboratories Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.